2025 Regulatory Affairs Benchmark finds half of medtech firms lack confidence in registration data quality, with most relying on manual processes—yet momentum grows for adopting automation, RIM systems, and AI to accelerate compliance and market access. ...
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance...
New global report explores the transformative role of digital platforms, AI, and connectivity in reshaping surgical precision, training, and patient outcomes across healthcare systems....
In-Depth Market Analysis Featuring Key Players Including Peijia Medical, HeMo Bioengineering, MicroPort NeuroTech, Zylox-Tonbridge, and Others – ResearchAndMarkets.com...
88% of Companies Set Modernization Plans in Motion Within Three Years ...
Personalized iPSC-derived dopaminergic neuron therapy shows early signs of safety and potential benefit in first-in-human study...
DelveInsight forecasts an 8% CAGR from 2025 to 2034, driven by improved diagnostics and expanding treatment options....
Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....
Under Montag’s leadership, the company reports 6.8% revenue growth and a 16.6% EBIT margin, while widening EPS guidance to address rising geopolitical and trade-related risks. ...
Phase II ADVANTAGE AF trial shows 73.4% freedom from arrhythmias and high safety profile, supporting expanded use of FARAWAVE and FARAPOINT PFA catheters in treating complex AF cases....
